Arden Trust’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.61M | Buy |
57,454
+2,374
| +4% | +$65.4K | 0.22% | 68 |
|
|
2024
Q1 | $1.53M | Buy |
55,080
+11,208
| +26% | +$311K | 0.21% | 79 |
|
|
2023
Q4 | $1.26M | Buy |
43,872
+4,369
| +11% | +$132K | 0.19% | 82 |
|
|
2023
Q3 | $1.31M | Sell |
39,503
-1,646
| -4% | -$58.2K | 0.22% | 75 |
|
|
2023
Q2 | $1.51M | Sell |
41,149
-15,256
| -27% | -$594K | 0.25% | 66 |
|
|
2023
Q1 | $2.3M | Sell |
56,405
-3,424
| -6% | -$148K | 0.42% | 49 |
|
|
2022
Q4 | $3.07M | Sell |
59,829
-5,311
| -8% | -$255K | 0.62% | 37 |
|
|
2022
Q3 | $2.85M | Sell |
65,140
-3,121
| -5% | -$152K | 0.72% | 31 |
|
|
2022
Q2 | $3.58M | Buy |
68,261
+11,965
| +21% | +$610K | 0.82% | 27 |
|
|
2022
Q1 | $2.92M | Sell |
56,296
-6,591
| -10% | -$342K | 0.57% | 41 |
|
|
2021
Q4 | $3.71M | Sell |
62,887
-970
| -2% | -$48.1K | 0.63% | 35 |
|
|
2021
Q3 | $2.75M | Sell |
63,857
-1,177
| -2% | -$52.1K | 0.47% | 44 |
|
|
2021
Q2 | $2.55M | Sell |
65,034
-9,604
| -13% | -$373K | 0.42% | 49 |
|
|
2021
Q1 | $2.7M | Sell |
74,638
-2,736
| -4% | -$97.1K | 0.46% | 40 |
|
|
2020
Q4 | $2.85M | Sell |
77,374
-15,983
| -17% | -$586K | 0.47% | 40 |
|
|
2020
Q3 | $3.25M | Sell |
93,357
-864
| -0.9% | -$30.3K | 0.58% | 29 |
|
|
2020
Q2 | $2.92M | Buy |
94,221
+315
| +0.3% | +$10.7K | 0.54% | 34 |
|
|
2020
Q1 | $2.91M | Sell |
93,906
-6,184
| -6% | -$211K | 0.58% | 29 |
|
|
2019
Q4 | $3.72M | Buy |
100,090
+6,774
| +7% | +$241K | 0.58% | 32 |
|
|
2019
Q3 | $3.18M | Sell |
93,316
-2,358
| -2% | -$85.7K | 0.52% | 36 |
|
|
2019
Q2 | $3.93M | Sell |
95,674
-4,282
| -4% | -$170K | 0.66% | 29 |
|
|
2019
Q1 | $4.03M | Sell |
99,956
-1,396
| -1% | -$55.9K | 0.65% | 28 |
|
|
2018
Q4 | $4.2M | Buy |
101,352
+244
| +0.2% | +$10.1K | 0.75% | 23 |
|
|
2018
Q3 | $4.23M | Buy |
101,108
+6,538
| +7% | +$252K | 0.66% | 25 |
|
|
2018
Q2 | $3.26M | Sell |
94,570
-2,083
| -2% | -$71.2K | 0.52% | 34 |
|
|
2018
Q1 | $3.25M | Sell |
96,653
-2,367
| -2% | -$81.4K | 0.51% | 36 |
|
|
2017
Q4 | $3.4M | Sell |
99,020
-3,445
| -3% | -$117K | 0.52% | 37 |
|
|
2017
Q3 | $3.47M | Sell |
102,465
-2,758
| -3% | -$88.6K | 0.53% | 35 |
|
|
2017
Q2 | $3.35M | Sell |
105,223
-3,782
| -3% | -$119K | 0.51% | 35 |
|
|
2017
Q1 | $3.54M | Sell |
109,005
-9,495
| -8% | -$299K | 0.55% | 36 |
|
|
2016
Q4 | $3.65M | Buy |
118,500
+2,756
| +2% | +$84.1K | 0.55% | 36 |
|
|
2016
Q3 | $3.72M | Sell |
115,744
-253,241
| -69% | -$8.47M | 0.57% | 38 |
|
|
2016
Q2 | $12.3K | Buy |
368,985
+5,764
| +2% | +$184K | 0.93% | 24 |
|
|
2016
Q1 | $10.2M | Buy |
363,221
+35,201
| +11% | +$1.01M | 0.82% | 29 |
|
|
2015
Q4 | $10M | Buy |
328,020
+17,712
| +6% | +$557K | 0.85% | 27 |
|
|
2015
Q3 | $9.25M | Buy |
310,308
+133,360
| +75% | +$4.28M | 0.76% | 29 |
|
|
2015
Q2 | $5.63K | Sell |
176,948
-1,235
| -0.7% | -$40.3K | 0.84% | 26 |
|
|
2015
Q1 | $5.88K | Buy |
178,183
+74,024
| +71% | +$2.35M | 0.86% | 28 |
|
|
2014
Q4 | $3.08M | Sell |
104,159
-6,780
| -6% | -$194K | 0.43% | 47 |
|
|
2014
Q3 | $3.11M | Sell |
110,939
-35,428
| -24% | -$994K | 0.43% | 45 |
|
|
2014
Q2 | $4.12M | Sell |
146,367
-2,861
| -2% | -$81.6K | 0.56% | 32 |
|
|
2014
Q1 | $4.55M | Sell |
149,228
-16,287
| -10% | -$486K | 0.56% | 34 |
|
|
2013
Q4 | $4.81M | Sell |
165,515
-233
| -0.1% | -$6.78K | 0.58% | 31 |
|
|
2013
Q3 | $4.52M | Sell |
165,748
-6,341
| -4% | -$173K | 0.58% | 28 |
|
|
2013
Q2 | $4.57M | Buy |
+172,089
| New | +$4.75M | 0.56% | 30 |
|
Other funds holding PFE
Arden Trust's PFE Position: Q2 2024 in Review
Arden Trust increased its Pfizer (PFE) stake by 4.3% in Q2 2024, buying an estimated $65.4K and bringing the position to 57,454 shares worth $1.61M. The position accounts for 0.22% of the portfolio, ranked #68.
Arden Trust first reported a position in PFE in Q2 2013 and has held it in 45 quarters since. The position peaked at $10.2M in Q1 2016. 2,873 funds tracked by Wall St. Rank hold PFE as of Q2 2024.
- Arden Trust held 57,454 shares of Pfizer worth $1.61M as of Q2 2024.
- Arden Trust bought 2,374 Pfizer shares in Q2 2024, an estimated $65.4K.
- Pfizer made up 0.22% of Arden Trust's portfolio in Q2 2024, its #68 holding.
- Arden Trust first reported a position in Pfizer in Q2 2013 and has held it in 45 quarters since.
- Arden Trust's Pfizer position peaked at $10.2M in Q1 2016.
- 2,873 funds tracked by Wall St. Rank held Pfizer as of Q2 2024.
Based on Arden Trust's 13F filing for Q2 2024, filed 9 Jul 2024.